High Note Wealth’s Avanos Medical AVNS Stock Holding History

High Note Wealth’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-115	Closed	-$1.65K	–	888
2025 Q1	$1.65K	Buy	+115	New	+$1.8K	﹤0.01%	704

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

High Note Wealth's AVNS Position: Q2 2025 in Review

High Note Wealth sold out of Avanos Medical (AVNS) in Q2 2025, closing a stake of 115 shares — an estimated $1.65K sold.

High Note Wealth first reported a position in AVNS in Q1 2025 and held it in 1 quarter. The position peaked at $1.65K in Q1 2025. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2025.

High Note Wealth reported no remaining Avanos Medical position as of Q2 2025 after selling out during the quarter.
High Note Wealth sold 115 Avanos Medical shares in Q2 2025, an estimated $1.65K.
High Note Wealth first reported a position in Avanos Medical in Q1 2025 and held it in 1 quarter.
High Note Wealth's Avanos Medical position peaked at $1.65K in Q1 2025.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2025.

Based on High Note Wealth's 13F filing for Q2 2025, filed 23 Jul 2025.